AzTrials
AzTrials

HIVCAPADONCT02903745

Knowledge Attitudes Beliefs and Practices Regarding HIV Among Teenagers in French Guiana

An observational study of HIV, run by Centre Hospitalier de Cayenne at 1 site in France.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

French Guiana is the French territory where the prevalence of HIV is highest. in order to determine the knowledge attitudes, beliefs, and practices among the target group of teenagers attending the public school system a survey was conducted in 2011. Read more about this study

Who is it for?
Ages 12 to 15 years
Conditions the study is for
HIV
What is being tested?
observational
How many people
1,603 participants
Where
1 siteFrance
Study dates
Jan 2011to Jun 2011
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 12 to 15 years
  • All sexes
  • No healthy volunteers
  • Child

Study population: randomly selected teenagers attending the public school system of french guiana

Who may be able to join

  • attending the public school system of french guiana

Who cannot join

  • refusal to participate

Trial locations and contacts

1 site in 1 country.

France1 site
  • Centre Hospitalier de Cayenne

    Cayenne, French Guiana, 97306

Other trials in France

About this study

French Guiana is the French territory where the prevalence of HIV is highest. in order to determine the knowledge attitudes, beliefs, and practices among the target group of teenagers attending the public school system a survey was conducted in 2011. schools and classrooms were randomly selected, and a structured questionnaire was administered. Descriptive statistics were obtained and multivariate logistic regression was used to determine predictors of main outcomes such as age at first sex.

the results will be used to guide prevention of HIV and sexually transmitted infections though the school system.

Conditions
HIV
Being tested
observational

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • observationalOther

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. knowledge, attitudes, behaviours, and practices relative to HIV/AIDS and sexually transmitted infections

    a structured questionnaire was used. it was administered face to face with usually 5 possible responses. Scores were established using similar questions exploring related areas of HIV.

    Measured: when the interview was conducted

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted16 Sep 2016 (estimated)
  2. Study startJan 2011
  3. Primary completionJan 2011
  4. Study completionJun 2011

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Time perspective
Cross-sectional
Enrolment
1,603 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02903745
Sponsor's protocol ID
capado
Acronym
CAPADO
Status last verified
Sep 2016
First submitted
6 Sep 2016
Last updated
16 Sep 2016
Results posted
No
Data monitoring committee
No

Questions about this trial

What is this clinical trial studying?

An observational study of HIV, run by Centre Hospitalier de Cayenne at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 16 Sep 2016. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

knowledge, attitudes, behaviours, and practices relative to HIV/AIDS and sexually transmitted infections (time frame: when the interview was conducted). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 16 Sep 2016.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in